Solid Biosciences advances gene therapy trials across muscle diseases

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. USO
10. SNOW

Go back to Solid Biosciences advances gene therapy trials across muscle diseases
(NASDAQ: SLDB) Delayed: 10.29 +0.41 (4.15%)
Previous Close $9.88    52 Week High $ 
Open $9.92    52 Week Low $ 
Day High $10.44    P/E N/A 
Day Low $9.75    EPS $ 
Volume 894,269